Predictive Oncology Share Holder Equity 2010-2025 | POAI
Predictive Oncology share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| Predictive Oncology Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $8 |
| 2022 | $22 |
| 2021 | $40 |
| 2020 | $3 |
| 2019 | $11 |
| 2018 | $0 |
| 2017 | $3 |
| 2016 | $1 |
| 2015 | $4 |
| 2014 | $-6 |
| 2013 | $-3 |
| 2012 | $-3 |
| 2011 | $-3 |
| 2010 | $-2 |
| 2009 | $-2 |
| Predictive Oncology Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $2 |
| 2024-06-30 | $4 |
| 2024-03-31 | $4 |
| 2023-12-31 | $8 |
| 2023-09-30 | $12 |
| 2023-06-30 | $15 |
| 2023-03-31 | $19 |
| 2022-12-31 | $22 |
| 2022-09-30 | $30 |
| 2022-06-30 | $34 |
| 2022-03-31 | $37 |
| 2021-12-31 | $40 |
| 2021-09-30 | $48 |
| 2021-06-30 | $53 |
| 2021-03-31 | $36 |
| 2020-12-31 | $3 |
| 2020-09-30 | $12 |
| 2020-06-30 | $12 |
| 2020-03-31 | $10 |
| 2019-12-31 | $11 |
| 2019-09-30 | $21 |
| 2019-06-30 | $22 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $3 |
| 2018-06-30 | $3 |
| 2018-03-31 | $5 |
| 2017-12-31 | $3 |
| 2017-09-30 | $2 |
| 2017-06-30 | $3 |
| 2017-03-31 | $4 |
| 2016-12-31 | $1 |
| 2016-09-30 | $0 |
| 2016-06-30 | $1 |
| 2016-03-31 | $3 |
| 2015-12-31 | $4 |
| 2015-09-30 | $6 |
| 2015-06-30 | $-6 |
| 2015-03-31 | $-6 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-3 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-2 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-2 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-2 |
| 2010-06-30 | $-2 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $-2 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.307B | 54.29 |
| Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
| Tempus AI (TEM) | United States | $10.781B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.415B | 68.98 |
| Privia Health (PRVA) | United States | $3.036B | 207.50 |
| Enovis (ENOV) | United States | $2.041B | 11.38 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.529B | 0.00 |
| Omnicell (OMCL) | United States | $1.315B | 23.21 |
| Azenta (AZTA) | United States | $1.223B | 56.83 |
| 10x Genomics (TXG) | United States | $1.125B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Talkspace (TALK) | United States | $0.500B | 149.50 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.368B | 816.67 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |